Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer


Unattributed VC | Alive

Total Raised


Last Raised

$10.74M | 3 yrs ago

About Curadim Pharma

Developer of new drugs. The company develops new drugs for the treatment of specified rare and intractable diseases. It focuses on immune-related diseases including multiple sclerosis (MS).

Curadim Pharma Headquarter Location

Otemachi Financial City Grand Cube, 3F 1-9-2 Otemachi, Chiyoda-ku

Tokyo, 100-0004,


81 3 4243 8654

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Curadim Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Curadim Pharma is included in 1 Expert Collection, including Biopharmaceuticals.



5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.